Insider Buying: Lakeland Industries (NASDAQ:LAKE) CEO Purchases 1,127 Shares of Stock

Lakeland Industries, Inc. (NASDAQ:LAKE) CEO James Jenkins purchased 1,127 shares of the business’s stock in a transaction on Monday, January 5th. The shares were acquired at an average price of $8.88 per share, for a total transaction of $10,007.76. Following the completion of the acquisition, the chief executive officer directly owned 94,565 shares in the company, valued at approximately $839,737.20. This represents a 1.21% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Lakeland Industries Stock Up 4.9%

Shares of Lakeland Industries stock traded up $0.43 during trading on Monday, reaching $9.28. 136,385 shares of the company traded hands, compared to its average volume of 165,168. The firm has a market capitalization of $91.04 million, a PE ratio of -2.11 and a beta of 1.29. Lakeland Industries, Inc. has a 1-year low of $7.77 and a 1-year high of $27.28. The company has a 50 day moving average price of $13.02 and a 200-day moving average price of $14.14. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.83 and a quick ratio of 1.48.

Lakeland Industries (NASDAQ:LAKE) last posted its quarterly earnings results on Wednesday, September 21st. The medical instruments supplier reported $0.36 earnings per share for the quarter. Lakeland Industries had a negative net margin of 19.41% and a negative return on equity of 7.80%. The firm had revenue of $27.47 million during the quarter. As a group, equities research analysts expect that Lakeland Industries, Inc. will post 0.48 earnings per share for the current fiscal year.

Lakeland Industries Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 24th. Shareholders of record on Monday, November 17th were issued a $0.03 dividend. The ex-dividend date was Monday, November 17th. This represents a $0.12 annualized dividend and a yield of 1.3%. Lakeland Industries’s dividend payout ratio is presently -2.73%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Wall Street Zen lowered Lakeland Industries from a “hold” rating to a “strong sell” rating in a research report on Saturday, December 13th. Roth Capital lowered their price objective on shares of Lakeland Industries from $27.00 to $19.00 and set a “buy” rating on the stock in a report on Wednesday, December 10th. DA Davidson reiterated a “neutral” rating and set a $14.00 price objective (down from $20.00) on shares of Lakeland Industries in a report on Wednesday, December 10th. Lake Street Capital lowered their target price on shares of Lakeland Industries from $26.00 to $19.00 and set a “buy” rating on the stock in a report on Wednesday, December 10th. Finally, UBS Group set a $14.00 price target on shares of Lakeland Industries in a research report on Wednesday, December 10th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $16.50.

Hedge Funds Weigh In On Lakeland Industries

Institutional investors and hedge funds have recently bought and sold shares of the company. BNP Paribas Financial Markets boosted its stake in Lakeland Industries by 87.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,795 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 839 shares during the period. Diversified Investment Strategies LLC lifted its holdings in shares of Lakeland Industries by 2.6% in the second quarter. Diversified Investment Strategies LLC now owns 40,000 shares of the medical instruments supplier’s stock worth $544,000 after buying an additional 1,000 shares in the last quarter. First Trust Advisors LP boosted its position in shares of Lakeland Industries by 4.2% in the second quarter. First Trust Advisors LP now owns 28,554 shares of the medical instruments supplier’s stock valued at $389,000 after acquiring an additional 1,149 shares during the period. Rhumbline Advisers boosted its position in shares of Lakeland Industries by 16.0% in the third quarter. Rhumbline Advisers now owns 13,415 shares of the medical instruments supplier’s stock valued at $199,000 after acquiring an additional 1,853 shares during the period. Finally, Salem Investment Counselors Inc. purchased a new position in Lakeland Industries during the second quarter valued at approximately $28,000. 71.69% of the stock is owned by institutional investors.

Lakeland Industries Company Profile

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.